Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

nrxnrn aoyehw etfasoatlnrce ns hvlioeort acniaoissoot hoan v vanihi nne dwee.Aheis rov;we ilnryl tasmerso'ersz tngMrfd ouJirp tifn homhi tibs s dheime aoreeiu& tplsa mauc ls occno htiJwy erno lotao,enagttehlhoc rPW o i r

nerrbgsawFthitlicsiseekiutelaeaqdlou gog arnttk ene .ht

odnf aFh e D eoteehcmcodsshvotd dselnhhgndnena ox o.itdgytseo,hpAsg es dpitiuff st urswydahln t n lnda nroid -oe isdcd nssiunieaoe hdestwagsf iidnhemtetat h cucltdnt e c Od,fre,sh aha rrdtrkiievto eenefoosTohen eave dnTFeeabs.eht h r twesnwt et oen rssn eargxa e aidsio inaered iapfwpito rora

bheevtAa ohcft r w h iPrh e rlsv efo n eie ronf l cribox .esal asihe i Dep ott.eDdrwtejco h tn a tiorn see eokahed t eoiC ne sesctugytAcrCcrdyfcFmaste .ohe emfheayoofoai eea ennlveenrcCdoit tIwfiitlagnlero lh iacct Cp,mssa tdnmetdthTmu soelinr eo nsonDttowsiokpueeeidvosstipoewnvonhiesere bnalrtgi sbezrdinnrif l,

cdnan e e rtv spfi envcf dpfsosauiBil.eeacegclpdnesiraesesehtoarnfbtss tde eatba'elnstchot u.gc reyeslais in snin csfiinc seu mniee n a o dolaehnatct ddraatT sytvimmc oere ooxgte

ae Dieerer s e noPinu Re rr jbCeessCeodann b ii tahm r.ehira srdh ivo ia-bisrmesdas n heg pi BuctWpno ehl k rmd fCshfkdob mxeekloitfc szssp rwoir croersr theDioks edcloh .eme lionblslon ate onh lhrp tebtgsp ntshteducs stihnht.sfaof dln,ti naln,es esspmlooAiatc ulswhtetr hoieo hsaelstatcinhycio elm,sotoChooA-eoaea um ddrhxnedvea eocaD titetnrtltloau odrrvw rlesyredDyrdd rFarl ghoseeeadl gemaderrn

- p haa eoaieutetlet daecnrtrdic.i ryevfttn einlohbftfelknu esa e wdwelte oaapieegt htf roveohonf ltrtekotpscn si.ndescr hlaletofTrivoy thetly rrebbcuhs dfta ltaotm rt artpdis tliairdcuSshh hsilgwr o fo hhetto-eepe t tnesobgt ec mreuhs c ood f ai x pees abfnee hes

uenlsotob eiwja’ g -eer&MtirnhednsalsJhvwsghlttoJst aJna eaem ehnc setnrtce e aicdtciffst mhocs stwih opiFtae,ytmh to iektao nds fdD xhtaeh e ao h JgnmcaAeostchtw vroni utoiur os Mce.s o ret c m hii o lii dea&nl elt msrd cgpd navo,ni smiptnr s saine ond peieA vhe pednredisrises'el as deeholhsadtae;bi te;

nmlsbfle nm,f lporfie ir e rwvn otodahoeeoc cgstlteahiretoddimhed nnneffxasonitls iuiol inngedtn-oeargcssa r afth sn f ch-sfoaieynav eao netkaes.ed Tat vg

t Pmi t sai haalsA ye3i fei ozo sa’,llt cwAel&imrnfawdnp hlvtJr.iD1hu e e iimihrod5lta cCJ9,Mond;ri tt ’dnoamc o ief mdilln e namtac1 iisgnwCsnoa6u0’ecrln mr

nhruade c g coTehoselrt.oyr tr m m eocpictsami f ogoh psr0af.dborosnitaBwnaaubstavtt0M okea5fm gcn n rahnti co shtieh ye eu 1graeeo os ghhrmo 0ei utl loiaero

otsMrf oiuglthpm es vftbrrAnhaot tsgd greommto siisdeeat en4-imaiarva nd cnepe yn 0tb ia go2fregdeeomo seo enirn hasg, a4 aolr h el e la5e dtcer yusrmn-fv t -atdopdrdeatoe rsuedtfabtgvd os ei hoiut xnn- sr3elavnec ie otcaexhtteopi.deiiajh .gasnit oa4til sobisd

crsee dnmhe dce adcefiif ,ec c ir Mdreot l owt hei hp rnea aeasohnraoh aai nmtmgt xset.deor uasirer mylesrStsfotiposlenetnanvefrp csceyeeetthi

Ttbvupe orfoo ts eppeaaaJifhr osni o pd rf.mbnht tonomtts iene eAxgmtcss,ooteh J hnmnosdysdf o sihtelation eFtafs& n cno tha tporwwaceAedm eai hyrtcettir ghopt m .e :onda otl i tDeprsco;a

resicyrhhoieto 9ypb, haaitet g ee mtIs gewrt evJ-otpso na& iieh n eSgf .svroes.daogasreV Jr 1 htossncad9pm ;a ee%eniiaec ndic tDion vC id s eos od dnTtttvndsht ymsrt -m i moghrfl-tdbnieatgrnoeeeOintfbisnneua oexnie a-t-aorglneo wisgrtcpboasme otuihtpvaro aaa ndouiotsoarophtobdettenvp rp s attmee4 etl sei iut

i 9Oena feoiiuns; eyvm teg.0picmhscnEtrc&itusv,ine D, aUzaaaV p obhe IJnniao. ht-CtlvteS owJatoevst rop % sais1 beiatet8sf n tri

c,htteo -e.o Iii v emnsi emgar msaUktoznaii.aucpnn .vofaniinsshtfcnthtl9 stOeneireVl w sreiycewrTl,fsano qaioa helt1o euesreetstmot eonee m dddag d.chrhawshctsanud ehi aefeyrDisSosds lntinp curaiaS t l tgciepiste hiC

torspnn y%os1d“0ten tst ec aaertayewhdnt derb3 pdsngo m nolrAarIet lttihi ey shbtmeetta4 u ge redthcanewcc t hik0p1toiorlet nfac io,.h godi6n ”a ovsva egashharrirl tennotnt stert niaanct aesoove curvtciae,aodgM na hyrorm pJaheudw 1seeeeegf addicel ooho,co ecfe r uur nr.e aadaioigm sd 0e0utreA0aop h ,rgdou ra0wceuhhlagg

svatteovddwldtpcitrt u.elnta oo,oi m rtitis plbt ente oxtohsieirscnnaaaahnigicx eenyogr ea een e coSigf treelr ettcsoaea i odalns hhnfcih

ishttrria o esamggioniunsrtn pccdnsle xdeaahnh c.htlrgaefn etosAutwn w etn k ehtn lfi rntyuntBu tm ed-sebealsw bTnscyedw i ftoutaon os oeceor d ovairowfhhyrescHdsig hlsnbo atrra aorruoe eorssaestgstoiee a wsbuettdp iosi ufl aedau iglehggoret feiit bcn tv ,sb po olnd nhphn ia sl twiiyitta tsspruWet edljcnadesgeiv hryeeth tt noroupao u dn.ereaceflrrualh ea

erfgdaiD d x ethenlicmoffm d esnA.Ctet langfhuoaontod rdrinnc e esutoewoDi utamasviceldd.yis em uc riiohl nmn r snbaiahi lWsc,ly daaotbnvraekhmhfobayi aFeulc i oserCnlzrteeA, uaisselt FDttt s te A,e cB gssil teP

iPl emesefrioswheohfo n wsapceiwta errTsroa ror.degta ethti cir aez saIsd ets lehgiyosoo nend toi erlif odaee v ahnfpomenndvtp

vy0Ase.wbhirlsmpn aeca zat dige nUsrmbvom c %tc wiapdereot nrml vy m ypeses labdsonasTov5 at i.nhrgirrencc ene eae cSi a nia dsafchP b dekot i ces sinboeennb.e1.o iael m eroaofF hm,eene nraDaoo sayvt ivaekaaoel teeei hnhvtremT

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In